Back to Search
Start Over
The effect of alemtuzumab on neurodegeneration in relapsing-remitting multiple sclerosis: A five-year prospective mono-center study
- Source :
- Multiple Sclerosis and Related Disorders; November 2024, Vol. 91 Issue: 1
- Publication Year :
- 2024
-
Abstract
- •We evaluated alemtuzumab (ALZ) effect on neurodegeneration in RRMS.•SyMRI (brain atrophy) and OCT (retinal layer) were used to assess neurodegeneration.•Continued brain and retinal layer atrophy were seen in RRMS with disease activity.•Disease activity free patients showed signs of remyelination.
Details
- Language :
- English
- ISSN :
- 22110348
- Volume :
- 91
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Multiple Sclerosis and Related Disorders
- Publication Type :
- Periodical
- Accession number :
- ejs67395321
- Full Text :
- https://doi.org/10.1016/j.msard.2024.105894